THE Purpose IS to Ensure Test Availability for Sars-Cov-2 After the Emergency Authorization Closes by Submitting an in Vitro Diagnostic or IVD Assay for Sars-Cov-2, Influenza (FLU) a, FLU B and Respiratory Syncytial Virus (RSV) Along With a Respirato
Contract Overview
Contract Amount: $22,300,000 ($22.3M)
Contractor: Hologic, Inc.
Awarding Agency: Department of Health and Human Services
Start Date: 2022-09-30
End Date: 2025-04-30
Contract Duration: 943 days
Daily Burn Rate: $23.6K/day
Official Description: THE PURPOSE IS TO ENSURE TEST AVAILABILITY FOR SARS-COV-2 AFTER THE EMERGENCY AUTHORIZATION CLOSES BY SUBMITTING AN IN VITRO DIAGNOSTIC OR IVD ASSAY FOR SARS-COV-2, INFLUENZA (FLU) A, FLU B AND RESPIRATORY SYNCYTIAL VIRUS (RSV) ALONG WITH A RESPIRATO
Place of Performance
Location: California, 92121